These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 1677674

  • 1. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.
    Santiago M, Westerink BH.
    J Neurochem; 1991 Sep; 57(3):738-47. PubMed ID: 1677674
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous recording of the release of nigral and striatal dopamine in the awake rat.
    Santiago M, Westerink BH.
    Neurochem Int; 1992 Mar; 20 Suppl():107S-110S. PubMed ID: 1365406
    [Abstract] [Full Text] [Related]

  • 3. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
    Santiago M, Westerink BH.
    Eur J Pharmacol; 1991 Oct 29; 204(1):79-85. PubMed ID: 1687125
    [Abstract] [Full Text] [Related]

  • 4. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats.
    Robertson GS, Damsma G, Fibiger HC.
    J Neurosci; 1991 Jul 29; 11(7):2209-16. PubMed ID: 1712381
    [Abstract] [Full Text] [Related]

  • 5. In vivo evidence for a concordant response of terminal and dendritic dopamine release during intranigral infusion of drugs.
    Westerink BH, Santiago M, De Vries JB.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Dec 29; 346(6):637-43. PubMed ID: 1362452
    [Abstract] [Full Text] [Related]

  • 6. Effects of D-2 agonists on the release of dopamine: localization of the mechanism of action.
    Timmerman W, De Vries JB, Westerink BH.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec 29; 342(6):650-4. PubMed ID: 1982893
    [Abstract] [Full Text] [Related]

  • 7. Responsiveness of striatal dopamine release in awake animals after chronic 1-methyl-4-phenylpyridinium ion-induced lesions of the substantia nigra.
    Santiago M, Westerink BH, Rollema H.
    J Neurochem; 1991 Apr 29; 56(4):1336-42. PubMed ID: 2002346
    [Abstract] [Full Text] [Related]

  • 8. Complex I inhibitor effect on the nigral and striatal release of dopamine in the presence and absence of nomifensine.
    Santiago M, Granero L, Machado A, Cano J.
    Eur J Pharmacol; 1995 Jul 14; 280(3):251-6. PubMed ID: 8566093
    [Abstract] [Full Text] [Related]

  • 9. YM-09151-2 but not l-sulpiride induces transient dopamine release in rat striatum via a tetrodotoxin-insensitive mechanism.
    Tomiyama K, Noguchi M, Koshikawa N, Kobayashi M.
    J Neurochem; 1993 May 14; 60(5):1690-5. PubMed ID: 8473891
    [Abstract] [Full Text] [Related]

  • 10. Microdialysis and striatal dopamine release: stereoselective actions of the enantiomers of N-0437.
    Timmerman W, Westerink BH, De Vries JB, Tepper PG, Horn AS.
    Eur J Pharmacol; 1989 Mar 14; 162(1):143-50. PubMed ID: 2566492
    [Abstract] [Full Text] [Related]

  • 11. Role of adenylate cyclase in the modulation of the release of dopamine: a microdialysis study in the striatum of the rat.
    Santiago M, Westerink BH.
    J Neurochem; 1990 Jul 14; 55(1):169-74. PubMed ID: 1693944
    [Abstract] [Full Text] [Related]

  • 12. Dopaminergic-cholinergic interactions in the striatum: the critical significance of calcium concentrations in brain microdialysis.
    de Boer P, Damsma G, Fibiger HC, Timmerman W, de Vries JB, Westerink BH.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov 14; 342(5):528-34. PubMed ID: 2090951
    [Abstract] [Full Text] [Related]

  • 13. Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis.
    Santiago M, Rollema H, de Vries JB, Westerink BH.
    Brain Res; 1991 Jan 11; 538(2):226-30. PubMed ID: 1707325
    [Abstract] [Full Text] [Related]

  • 14. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: I. Studies using veratrine and ouabain.
    Fairbrother IS, Arbuthnott GW, Kelly JS, Butcher SP.
    J Neurochem; 1990 Jun 11; 54(6):1834-43. PubMed ID: 2338544
    [Abstract] [Full Text] [Related]

  • 15. Nigral and striatal comparative study of the neurotoxic action of 1-methyl-4-phenylpyridinium ion: involvement of dopamine uptake system.
    Santiago M, Machado A, Cano J.
    J Neurochem; 1996 Mar 11; 66(3):1182-90. PubMed ID: 8769882
    [Abstract] [Full Text] [Related]

  • 16. Effect of quinine on autoreceptor-regulated dopamine release in the rat striatum.
    Tanaka T, Vincent SR, Nomikos GG, Fibiger HC.
    J Neurochem; 1992 Nov 11; 59(5):1640-5. PubMed ID: 1357098
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
    Magnusson O, Mohringe B, Fowler CJ.
    J Neural Transm; 1987 Nov 11; 69(3-4):163-77. PubMed ID: 2957465
    [Abstract] [Full Text] [Related]

  • 18. Regulation of dopamine D1 and D2 receptors on striatal acetylcholine release in rats.
    Ikarashi Y, Takahashi A, Ishimaru H, Arai T, Maruyama Y.
    Brain Res Bull; 1997 Nov 11; 43(1):107-15. PubMed ID: 9205804
    [Abstract] [Full Text] [Related]

  • 19. In vivo release of dopamine from rat striatum, substantia nigra and prefrontal cortex: differential modulation by baclofen.
    Santiago M, Machado A, Cano J.
    Br J Pharmacol; 1993 Jul 11; 109(3):814-8. PubMed ID: 7689406
    [Abstract] [Full Text] [Related]

  • 20. Dopaminergic regulation of serotonin release in the substantia nigra of the freely moving rat using microdialysis.
    Thorré K, Sarre S, Smolders I, Ebinger G, Michotte Y.
    Brain Res; 1998 Jun 15; 796(1-2):107-16. PubMed ID: 9689460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.